Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002698
Filing Date
2019-04-29
Accepted
2019-04-29 17:00:14
Documents
4
Period of Report
2019-06-11
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238635zdef14a.htm DEF 14A 631468
2 G18891.JPG g18891.jpg GRAPHIC 16439
3 G26772BCI001.GIF g26772bci001.gif GRAPHIC 145588
4 G26772BCI002.GIF g26772bci002.gif GRAPHIC 137570
  Complete submission text file 0001047469-19-002698.txt   1045475
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 19776836
SIC: 2834 Pharmaceutical Preparations